A detailed history of Mv Capital Management, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Mv Capital Management, Inc. holds 104 shares of RPRX stock, worth $3,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 57 82.46%
Holding current value
$3,779
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$30.85 - $36.14 $1,449 - $1,698
47 Added 82.46%
104 $3,000
Q1 2025

Apr 15, 2025

BUY
$25.75 - $33.86 $463 - $609
18 Added 46.15%
57 $1,000
Q4 2024

Feb 12, 2025

BUY
$24.28 - $28.39 $655 - $766
27 Added 225.0%
39 $0
Q3 2024

Nov 04, 2024

SELL
$25.63 - $29.27 $25 - $29
-1 Reduced 7.69%
12 $0
Q2 2024

Aug 01, 2024

BUY
$26.26 - $29.9 $210 - $239
8 Added 160.0%
13 $0
Q1 2024

Apr 18, 2024

BUY
$27.46 - $31.33 $82 - $93
3 Added 150.0%
5 $0
Q4 2023

Jan 29, 2024

BUY
$26.21 - $29.22 $52 - $58
2 New
2 $0

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $15.9B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.